Source: Annual Congress 2007 - Role of genomics and biological tools in the work-up of interstitial lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Selman, G. Carrillo, A. Estrada, M. Mejia, M. Gaxiola, C. Navarro, R. Perez-Padilla, T. King, A. Pardo, N. Kaminski (Mexico, DF, Mexico; San Francisco, CA, Pittsburgh, PA, United States Of America). Accelerated variant of idiopathic pulmonary fibrosis: clinical and molecular behaviour. Eur Respir J 2007; 30: Suppl. 51, 2952

Member's Comments

No comment yet.

Related content which might interest you: The genetic basis of idiopathic pulmonary fibrosis Source: Eur Respir J 2015; 45: 1717-1727 Year: 2015 Combined idiopathic pulmonary fibrosis and emphysema: functional characterization Source: Eur Respir J 2004; 24: Suppl. 48, 283s Year: 2004 Novel rare genetic variants in idiopathic pulmonary fibrosis Source: Eur Respir J, 56 (6) 2003252; 10.1183/13993003.03252-2020 Year: 2020 PP217 – Modeling idiopathic pulmonary fibrosis on a lung-on-chip Source: ERS Lung Science Conference 2021 Year: 2021 The clinical relevance of autoimmunity in idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Clinical course of idiopathic pulmonary fibrosis (IPF): Prediction and outcome Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Idiopathic pulmonary fibrosis: another step in understanding the burden of this disease Source: Eur Respir J 2016; 48: 26-28 Year: 2016 Idiopathic pulmonary fibrosis: recent milestones in disease management Source: Eur Respir Rev 2012; 21: 140 Year: 2012 Idiopathic pulmonary fibrosis: classification, epidemiology, course and prognosis Source: International Congress 2016 – Russia Session Year: 2016 Idiopathic pulmonary fibrosis phenotypes: Identification of new clinico-pathological stigmata Source: Annual Congress 2010 - Clinical issues in idiopathic pulmonary fibrosis Year: 2010 Real-life experience with pirfenidon in idiopathic pulmonary fibrosis: Does early treatment start predict better therapy adherence? Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Age-driven developmental drift in the pathogenesis of idiopathic pulmonary fibrosis Source: Eur Respir J 2016; 48: 538-552 Year: 2016 Distinct clinical and pathological phenotypes in IPF Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Idiopathic pulmonary fibrosis (IPF): epidemiology, biology, diagnosis and treatment Source: Virtual Congress 2020 – When the lung gets stiff Year: 2020 Mechanisms of treatment response to pirfenidone of idiopathic pulmonary fibrosis (IPF) patients Source: International Congress 2016 – IPF pathogenesis Year: 2016 Familial cases of idiopathic pulmonary fibrosis: Clinical observation Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011 Clinical characteristics and survival in patients with idiopathic pulmonary fibrosis with and without associated emphysema Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Genetic susceptibility and pulmonary fibrosis Source: Annual Congress 2005 - Idiopathic pulmonary fibrosis: new concepts in its pathogenesis and management Year: 2005 Evaluating disease severity in idiopathic pulmonary fibrosis Source: Eur Respir Rev, 26 (145) 170051; 10.1183/16000617.0051-2017 Year: 2017